Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 56,902 | 65,675 | 67,771 | 111,231 | 88,341 |
| Cost of Goods | 25,397 | 31,683 | 31,043 | 42,754 | 39,182 |
| Gross Profit | 31,505 | 33,992 | 36,728 | 68,477 | 49,159 |
| Operating Expenses | 60,017 | 30,027 | 43,452 | 33,090 | 29,058 |
| Operating Income | -28,115 | 4,648 | -6,681 | 36,141 | 20,283 |
| Interest Expense | 148 | 220 | 256 | 341 | 372 |
| Other Income | -834 | 205 | 335 | 735 | -160 |
| Pre-tax Income | -29,097 | 4,633 | -6,602 | 36,535 | 19,751 |
| Income Tax | 724 | -1,072 | 736 | 7,783 | 4,411 |
| Net Income Continuous | -29,821 | 5,705 | -7,338 | 28,752 | 15,340 |
| Net Income | $-29,821 | $5,705 | $-7,338 | $28,752 | $15,340 |
| EPS Basic Total Ops | -0.68 | 0.13 | -0.17 | 0.66 | 0.35 |
| EPS Basic Continuous Ops | -0.68 | 0.13 | -0.17 | 0.66 | 0.35 |
| EPS Diluted Total Ops | -0.68 | 0.12 | -0.16 | 0.65 | 0.35 |
| EPS Diluted Continuous Ops | -0.68 | 0.12 | -0.17 | 0.65 | 0.35 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.20 | 0.17 | 0.66 | 0.35 |
| EBITDA(a) | $-23,931 | $8,717 | $-2,574 | $40,293 | $24,466 |